Personalized Compounded Semaglutide
US$ 26.00
glp-1/gip agonists The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology The Effects of Dual GLP-1/GIP
Description
The data on newer agents are even more striking, with tirzepatide demonstrating significantly greater weight loss (20.2%) than semaglutide (13.7%) in head-to-head trials
Multiple trials are investigating the effects of GLP-1 RAs on HF
What are the risks and benefits of taking weight loss medication versus not taking it
Significantly, during the initial weeks of therapy with GLP-1 receptor agonists, a common question is, does GLP-1 make you tired
Yes, Saxenda is a GLP-1 receptor agonist
Both companies are testing oral GLP-1 drugs
